The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study.

L YangZ LvW XiaW ZhangY XinH YuanY ChenX HuY LvQ XuX WengChao Ni

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2017)

Aspirin could decrease CTCs numbers and block EMT transition in MCC patients and part of MBC patients.

Keyphrases

circulating tumor cells
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
low dose
squamous cell carcinoma
type diabetes
clinical trial
cardiovascular disease
epithelial mesenchymal transition
cardiovascular events
coronary artery disease
patient reported outcomes
open label